NCT07332494Not yet recruiting
Digital Remote Management for Care and Continuous Optimization Versus Usual Care in Patients With Coronary Heart Disease (DigiCare-CHD)
Source: ClinicalTrials.gov · Last updated 12 Jan 2026
Brief summary (registry, in English)
The DigiCare-CHD study is an investigator-initiated, multicenter, open-label, parallel-group randomized controlled trial. It aims to evaluated the efficacy of a smartphone-based digital remote management platform compared to usual care in achieving dual goal attainment of blood pressure and LDL-cholesterol levels in patients with coronary heart disease following percutaneous coronary intervention.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 792 (estimated)
- First submitted
- 31 Dec 2025
- Start date
- Jan 2026
- Primary completion date
- Jul 2027
- Lead sponsor
- Beijing Anzhen Hospital
- Diseases
- Coronary artery disease
- NCT number
- NCT07332494
What you commit to
- Study type: Interventional
- Planned participants: 792
- From Jan 2026 to the primary completion date, Jul 2027
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe sensory (hearing/vision) or cognitive impairment precluding device use
- Conditions affecting adherence (e.g., substance use disorder, history of alcohol abuse)
Lab values
- Heart Failure: NYHA Class III-IV or LVEF \< 40%.
- Severe hepatic dysfunction (ALT/AST ≥3xULN or Total Bilirubin \>1.5 mg/dl)
- Severe renal dysfunction (eGFR \< 30 ml/min/1.73m² or requiring dialysis)
Other
- Uncontrolled hypothyroidism (TSH \>1.5xULN or \>10 mIU/L, or unstable dosage within 6 weeks)
- Life expectancy \< 1 year due to non-cardiovascular comorbidities
Who the study is looking for
- Age 18-75 years
- Diagnosis of Acute Coronary Syndrome (ACS) or Chronic Coronary Syndrome (CCS)
- Status post-successful percutaneous coronary intervention (PCI).
- Possession of a smartphone and ability to operate the application (independently or with caregiver assistance).
- Provision of written informed consent.
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (4)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Beijing Tongren Hospital, Capital Medical University, Beijing, China Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
| 13810720787 Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
| The First Affiliated Hospital of Dalian Medical University, Dalian, China Coordinator of this site? Confirm its status | Dalian | China | Unknown status |
| The First Hospital of Jilin University, Changchun, China Coordinator of this site? Confirm its status | Jilin City | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.